Acculis

Acculis was a medical technology company focused on the development of advanced microwave tissue ablation (MTA) systems for oncology applications. The company's primary product, the Accu2 Microwave Ablation System, utilized high-frequency microwave energy to treat cancerous tumors in the liver and lungs. This technology was designed to provide clinicians with a faster and more predictable method for tissue coagulation compared to traditional radiofrequency ablation. By offering a high-power, single-antenna solution, Acculis aimed to improve surgical outcomes for patients with non-resectable tumors. In early 2010, the company was acquired by AngioDynamics, a leading provider of minimally invasive medical devices. The acquisition integrated Acculis's MTA technology into AngioDynamics's broader oncology and vascular portfolio.